verapamil has been researched along with pimaric acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Connelly, M; Fatima, I; Gautam, LN; González, MA; Ling, T; Miranda-Carboni, G; Rivas, F; Tran, M; Wood, RK | 1 |
Ambrosio, SR; Bendhack, LM; Bonaventura, D; da Costa, FB; de Oliveira, AM; dos Anjos Neto Filho, M; Melo, MC; Tirapelli, CR | 1 |
2 other study(ies) available for verapamil and pimaric acid
Article | Year |
---|---|
(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; MCF-7 Cells; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2015 |
Pimaradienoic acid inhibits vascular contraction and induces hypotension in normotensive rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Calcium; Calcium Chloride; Cytosol; Diterpenes; Dose-Response Relationship, Drug; In Vitro Techniques; Injections, Intravenous; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Wistar; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 2008 |